4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Conexeu Sciences Inc. (CNXU) operates in the Biotechnology industry and is headquartered in Reno, United States. Its market capitalization is roughly $299 million. In the fiscal year ended 2025-10-31, CNXU reported $0M in revenue and ($4M) in net income.
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair.
Interactive charts & full statements →
| Income statement | 2025-10-31 | 2024-10-31 |
|---|---|---|
| Total Revenue | $0M | $0M |
| Operating Income (EBIT) | ($4M) | ($1M) |
| Net Income | ($4M) | ($0M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-04-30 | 2026-01-31 | 2025-04-30 | 2025-01-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($2M) | ($2M) | ($0M) | ($0M) |
| Net Income | ($2M) | ($2M) | ($0M) | ($0M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-10-31 | 2024-10-31 |
|---|---|---|
| Total Assets | $8M | $0M |
| Total Liabilities | $0M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CNXU viewer.
About TickerBase · Data methodology & sources